UK BMT Pharmacists’ Group has recently updated its training passport

The UK BMT Pharmacists’ Group has recently updated its training passport that is designed to support pharmacists working in the area of adult haematopoietic stem cell transplantation (HSCT). It is based around the FACT-JACIE International Standards for Haematopoietic Cellular Therapy (currently 7th edition, 2018) which require that all designated pharmacists providing a service to HSCT patients must demonstrate the minimum JACIE requirements for continuing accreditation. We hope that the passport will continue to provide a useful core template that individual centres can build their own training programmes around. The passport also contains a set of assessment questions – for a copy of the model answers please email [email protected].

To access the document click here: https://www.bopa.org.uk/bmt-training-passport/

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article